EUVIMEDEUVIMED entdecken
Crossref

Phosphaturic mesenchymal tumor: management and outcomes of ten patients treated at a single institution

Marcos R Gonzalez, Neel Patel, Joseph J Connolly, Yin P Hung, Connie Y Chang, Santiago A Lozano-Calderon

Skeletal Radiology · 2024

DOI: 10.1007/s00256-024-04614-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skeletal Radiology, 2024. Verfasst von Marcos R Gonzalez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02144, US…. Hauptthemen laut MEDLINE: Osteomalacia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Phosphaturic mesenchymal tumor (PMT) is a rare tumor that causes tumor-induced osteomalacia. Patients present with non-specific symptoms secondary to renal phosphate wasting and decreased bone mineralization. We sought to assess: (1) What are the common presenting features, laboratory and imaging findings, histologic findings of phosphaturic mesenchymal tumors? (2) What are the available treatment strategies for phosphaturic mesenchymal tumors and their long-term outcomes in terms of local recurrence and symptom control after treatment? METHODS: We retrospectively identified patients with a histologic diagnosis of PMT located in the axial or appendicular skeleton, or surrounding soft tissues. A total of 10 patients were finally included in our study. RESULTS: Median tumor size was 1.9 cm (range, 1.1 to 6.1) and median time from symptom onset to diagnosis was 3 years (range, 0.5 to 15 years). All patients but one presented with hypophosphatemia (median 1.9 mg/dL, range 1.2 to 3.2). Pre-operative FGF-23 was elevated in all cases (median 423.5 RU/mL, range 235 to 8950). Six patients underwent surgical resection, three were treated percutaneously (radiofrequency ablation or cryoablation), and one refused treatment. Only one patient developed local recurrence and no patients developed metastatic disease. At last follow-up, nine patients showed no evidence of disease and one was alive with disease. CONCLUSION: Phosphaturic mesenchymal tumor is a rare tumor presenting with non-specific symptoms. Surgery is the standard treatment when negative margins can be achieved without significant morbidity. In patients with small tumors in surgically-inaccessible areas, radiofrequency ablation or cryoablation can be performed successfully.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteomalaciaHumansMaleFemaleRetrospective StudiesAdultMiddle AgedMesenchymomaAdolescentTreatment OutcomeNeoplasms, Connective TissueParaneoplastic SyndromesFibroblast Growth Factor-23ChildAgedHypophosphatemiaYoung AdultMagnetic Resonance Imaging

Stichwörter der Autor:innen

CryoablationPhosphaturic mesenchymal tumorRadiofrequency ablationSurgery

Substanzen

Fibroblast Growth Factor-23

Autor:innen und Institutionen

  • Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02144, USA.
  • Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02144, USA.
  • Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02144, USA.
  • Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02144, USA. slozanocalderon@mgh.harvard.edu.

Zitieren

APA

Gonzalez, M. R., Patel, N., Connolly, J. J., Hung, Y. P., Chang, C. Y., & Lozano-Calderon, S. A. (2024). Phosphaturic mesenchymal tumor: management and outcomes of ten patients treated at a single institution. Skeletal Radiology. https://doi.org/10.1007/s00256-024-04614-6

Vancouver

Gonzalez MR, Patel N, Connolly JJ, Hung YP, Chang CY, Lozano-Calderon SA. Phosphaturic mesenchymal tumor: management and outcomes of ten patients treated at a single institution. Skeletal Radiology. 2024. doi:10.1007/s00256-024-04614-6

BibTeX
@article{Gonzalez2024,
  author = {Gonzalez, Marcos R and Patel, Neel and Connolly, Joseph J and Hung, Yin P and Chang, Connie Y and Lozano-Calderon, Santiago A},
  title = {Phosphaturic mesenchymal tumor: management and outcomes of ten patients treated at a single institution},
  journal = {Skeletal Radiology},
  year = {2024},
  doi = {10.1007/s00256-024-04614-6}
}
Kostenlos starten →